A Phase I, Exploratory Study to Assess the Pharmacokinetics of Single Oral Doses and a Single Intravenous Radiolabelled Microtracer Dose of AZD5122 in Healthy Male Subjects.
Latest Information Update: 08 Nov 2021
Latest Information Update: 08 Nov 2021